Drawing for PATIENT MATCH OPTIMIZER

USPTO serial 90555439

PATIENT MATCH OPTIMIZER

Reviewed by CopyMark Law Group

Reg. 6726569Status 700Registered
Filing date
Status date
Registration date
May 24, 2022
Examiner
SINGLETON, RUDY
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PATIENT MATCH OPTIMIZER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jenevieve Maerker, Esq.

Jenevieve Maerker, Esq. FOLEY HOAG LLP155 SEAPORT BOULEVARDBOSTON, MA 02210UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Recruitment advertising services, namely, distributing information about clinical trials for the purpose of recruiting patients for participation in clinical trials; Business consulting and management in the field of clinical trials, namely, compiling and analyzing clinical and patient data for purposes of improving clinical trial operation, design, and patient enrollment; Business consulting and management in the field of clinical trials, namely, providing information on patient population data and patient enrollment; Business consulting services, namely, providing assistance to medical personnel in the identification, recruitment, and enrollment of subjects for medical and scientific research and clinical trials and studies; Recruitment and enrollment of subjects for medical and scientific research and clinical trials and studies; Collection and analysis of patient data for business purposes; Business consulting and management in the field of clinical trials, namely, providing information management services; Maintaining a registry of patients, namely, compilation of patient information into computer databases for business purposes; Providing clinical trial data and patient data, and analysis of such data, all for use in clinical trial recruitment of patients for clinical trials; Consulting services in the field of patient identification for the purpose of recruitment for clinical trialsACTIVE—
042Providing medical and scientific research information in the field of clinical trials; Software as a service (SAAS) services featuring software for matching cancer patients with appropriate clinical trials; Software as a service (SaaS) services featuring software for use in database management in the field of clinical trials; Software as a service (SaaS) services featuring software for management of clinical trials, namely, for planning clinical trials, identifying and recruiting patients for participation in clinical trials, and matching patients with clinical trials; Software as a service (SaaS) services featuring software for collecting, managing, and analyzing clinical trial data; Providing clinical trial data and patient data, and analysis of such data, all for pharmaceutical research and development; Consulting services in the field of design, planning, and implementation of clinical trialsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 24, 2022NRCSNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 24, 2022R.SRREGISTERED-SUPPLEMENTAL REGISTERYour mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application.
Apr 7, 2022PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 31, 2022ALIEASSIGNED TO LIE—
Mar 30, 2022CNTAAPPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER—
Mar 24, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 24, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 24, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 11, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 11, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 11, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 23, 2021DOCKASSIGNED TO EXAMINER—
Jun 1, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 5, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance